It appears that genes involved with drug metabolism such as MDR1, COX2 and CYP2C19 [52, 62, 71, 76, 83, 85, 100] appear to have major influences on stroke outcome which may be explained by the inflammatory cascade in the recovery process of AIS. Here, CYP2C19 is linked to stroke disorder.